Bridge Pharmaceuticals Private Limited
About Bridge Pharmaceuticals Private Limited
Data last updated:
Bridge Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 September 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PTC041672. Its GSTIN is 36AACCB2251R1ZG (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Bomma Sowjanya (Managing Director) and Kistam Vijayalaxmi.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Plot No.89 Prashanthi Nagar Ida Kukatpally Hyderabad – 072, Telangana, India – 500072.
As per the financials filed for FY 2021, the company reported a revenue of ₹19.42 Lakh, a decline of 70% compared to the previous year. For the same year it recorded a net profit of ₹40,111 (net margin 2.1%) and EBITDA of ₹1.9 Lakh (EBITDA margin 9.8%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 21% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No.89 Prashanthi Nagar Ida Kukatpally Hyderabad – 072, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bridge Pharmaceuticals Private Limited
The main business activity of Bridge Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bridge Pharmaceuticals Private Limited FY 2021 filings available
Bridge Pharmaceuticals Private Limited reported revenue of ₹19.42 Lakh (down 70% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Bridge Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 21% over five years, including a 70% fall in the latest year. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bridge Pharmaceuticals Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.9 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹40,111 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bridge Pharmaceuticals Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bridge Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bridge Pharmaceuticals Private Limited
Bridge Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ivy Nelson Pharmaceuticals Private Limited | ₹19.48 Lakh (FY 2019) | •••• | •••• | -14.0% | •••• | Piplod, Gujarat, India |
| Ramedi Pharmaceuticals Private Limited | ₹19.47 Lakh (FY 2025) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Vidan Pharmaceuticals Private Limited | ₹19.46 Lakh (FY 2021) | •••• | •••• | 213.0% | •••• | New Delhi, Delhi, India |
| Bromartis Pharmaceuticals Private Limited | ₹19.45 Lakh (FY 2017) | •••• | •••• | -78.0% | •••• | Jaipur, Rajasthan, India |
| Heartkind Pharmaceuticals Private Limited | ₹19.43 Lakh (FY 2021) | •••• | •••• | •••• | Jaipur, Rajasthan, India | |
| Bridge Pharmaceuticals Private Limited this company | ₹19.42 Lakh (FY 2021) | •••• | •••• | -70.0% | •••• | Hyderabad, Telangana, India |
| Nexx Medicine Shoppee Technologies Private Limited | ₹19.41 Lakh (FY 2019) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Saigaur Lifescience Private Limited | ₹19.4 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Aurangabad, Maharashtra, India |
| Rosemount Pharmaceuticals Private Limited | ₹19.4 Lakh (FY 2016) | •••• | •••• | 88.0% | •••• | Patna, Bihar, India |
| Sascure Formulations Private Limited | ₹19.34 Lakh (FY 2025) | •••• | •••• | 22.0% | •••• | Delhi, India |
| Greenhouse Pharmaceuticals Private Limited | ₹19.34 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Dindigul, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Bridge Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Bridge Pharmaceuticals Private Limited
Bridge Pharmaceuticals Private Limited is audited by SRINIVAS AND POORNA for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SRINIVAS AND POORNA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Bridge Pharmaceuticals Private Limited
Bridge Pharmaceuticals has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bomma Sowjanya | Managing Director | 19 Mar 2022 | 4 Years 6 Months | Current |
| Kistam Vijayalaxmi | Director | 19 Mar 2022 | 4 Years 6 Months | Current |
Ownership and Shareholding of Bridge Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bridge Pharmaceuticals Private Limited
Bridge Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bridge Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Bridge Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Bridge Pharmaceuticals Private Limited
Bridge Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2003PTC041672. The current CIN is U24239TG2003PTC041672, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2003PTC041672 | Current |
| U24239AP2003PTC041672 | Previous |
Recent Activity on Bridge Pharmaceuticals Private Limited
Bridge Pharmaceuticals Private Limited has 9 board changes on record since 2012: 2 appointments and 7 cessations. The latest: Medarametla Sambasiva Rao ceased to be Director on 06 May 2022.
Credit Ratings, Litigation & Regulatory Alerts for Bridge Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bridge Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bridge Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bridge Pharmaceuticals Private Limited
Bridge Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCB2251R1ZG | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bridge Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bridge Pharmaceuticals Private Limited
Bridge Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 September 2003 (23+ years old) and is registered under CIN U24239TG2003PTC041672.
Bridge Pharmaceuticals reported revenue of ₹19.42 Lakh for FY 2021 (down 70% YoY).
Bridge Pharmaceuticals has 2 current directors:
- Bomma Sowjanya - Managing Director
- Kistam Vijayalaxmi - Director
Bridge Pharmaceuticals reported a net profit of ₹40,111 (net margin 2.1%) and EBITDA of ₹1.9 Lakh (EBITDA margin 9.8%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bridge Pharmaceuticals is -30% over three years and -21% over five years. In the latest year (FY 2021) revenue fell 70%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bridge Pharmaceuticals is 36AACCB2251R1ZG, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Bridge Pharmaceuticals is U24239TG2003PTC041672. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bridge Pharmaceuticals was incorporated on 11 September 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Bridge Pharmaceuticals by revenue are Ivy Nelson Pharmaceuticals Private Limited, Ramedi Pharmaceuticals Private Limited, Vidan Pharmaceuticals Private Limited, Bromartis Pharmaceuticals Private Limited, Heartkind Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Medarametla Sambasiva Rao ceased to be Director on 06 May 2022. Raj Nandan Reddy Chinnapolu ceased to be Director on 06 May 2022. Bomma Sowjanya ceased to be Additional Director on 28 Mar 2022. Bridge Pharmaceuticals has 9 board changes on record in total.
The registered office of Bridge Pharmaceuticals is at Plot No.89 Prashanthi Nagar Ida Kukatpally Hyderabad – 072, Telangana, India – 500072.